BioCentury | Jun 8, 2015
Clinical News

Talion bepotastine besilate regulatory update

...Mitsubishi Tanabe and Ube said Japan approved an expanded label for allergy drug Talion bepotastine besilate tablets...
...Talion. Mitsubishi Tanabe Pharma Corp. (Tokyo:4508), Osaka, Japan Ube Industries Ltd. (Tokyo:4208), Tokyo, Japan Product: Talion...
...Pharma Corp. (Tokyo:4508), Osaka, Japan Ube Industries Ltd. (Tokyo:4208), Tokyo, Japan Product: Talion bepotastine besilate ( TAU-284...
BioCentury | May 14, 2012
Clinical News

Beposone: Phase II data

...exclusive North American rights to nasal formulations of bepotastine from Mitsubishi, which markets bepotastine as Talion...
BioCentury | Feb 6, 2012
Clinical News

Beposone: Completed Phase II enrollment

...American rights to nasal formulations of bepotastine besylate from Mitsubishi Tanabe, which markets bepotastine as Talion...
...Osaka:4508), Osaka, Japan Product: Beposone Business: Inflammation Molecular target: NA Description: Nasal spray combination of bepotastine besilate...
BioCentury | Jan 9, 2012
Clinical News

Beposone: Phase II started

...to compare twice-daily beposone nasal spray vs. a nasal spray of each of beposone's components (bepotastine besilate...
...North American rights to nasal formulations of bepotastine besilate from Mitsubishi Tanabe, which markets bepotastine as Talion...
...Osaka:4508), Osaka, Japan Product: Beposone Business: Inflammation Molecular target: NA Description: Nasal spray combination of bepotastine besilate...
BioCentury | May 9, 2011
Clinical News

Bepotastine besilate nasal spray: Phase II data

...exclusive North American rights to nasal formulations of bepotastine from Mitsubishi, which markets bepotastine as Talion...
...Ista Pharmaceuticals Inc. (NASDAQ:ISTA), Irvine, Calif. Mitsubishi Tanabe Pharma Corp. (Tokyo:4508; Osaka:4508), Osaka, Japan Product: Bepotastine besilate...
BioCentury | Dec 20, 2010
Clinical News

Bepotastine besilate nasal spray: Phase II started

...Ista began a placebo-controlled, U.S. Phase II trial to evaluate twice-daily bepotastine besilate nasal spray for 2...
...exclusive North American rights to nasal formulations of bepotastine from Mitsubishi, which markets bepotastine as Talion...
...Ista Pharmaceuticals Inc. (NASDAQ:ISTA), Irvine, Calif. Mitsubishi Tanabe Pharma Corp. (Tokyo:4508; Osaka:4508), Osaka, Japan Product: Bepotastine besilate...
BioCentury | Oct 25, 2010
Clinical News

Bepotastine besilate nasal spray: Preliminary Phase I/II data

...exclusive North American rights to nasal formulations of bepotastine from Mitsubishi, which markets bepotastine as Talion...
...Ista Pharmaceuticals Inc. (NASDAQ:ISTA), Irvine, Calif. Mitsubishi Tanabe Pharma Corp. (Tokyo:4508; Osaka:4508), Osaka, Japan Product: Bepotastine besilate...
BioCentury | Jul 19, 2010
Clinical News

Bepotastine besilate nasal spray: Phase I/II started

...exclusive North American rights to nasal formulations of bepotastine from Mitsubishi, which markets bepotastine as Talion...
...Ista Pharmaceuticals Inc. (NASDAQ:ISTA), Irvine, Calif. Mitsubishi Tanabe Pharma Corp. (Tokyo:4508; Osaka:4508), Osaka, Japan Product: Bepotastine besilate...
BioCentury | Nov 16, 2009
Clinical News

Bepreve: Additional Phase III data

...the product outside of certain Asian countries from Mitsubishi in 2001. Mitsubishi markets bepotastine as Talion...
...Corp. (Tokyo:4508; Osaka:4508), Osaka, Japan Senju Pharmaceutical Co. Ltd. , Osaka, Japan Product: Bepreve ( Talion...
BioCentury | Sep 14, 2009
Clinical News

Bepreve regulatory update

...outside of certain Asian countries from Mitsubishi Tanabe in 2001. Mitsubishi Tanabe markets bepotastine as Talion...
...Corp. (Tokyo:4508; Osaka:4508), Osaka, Japan Senju Pharmaceutical Co. Ltd. , Osaka, Japan Product: Bepreve ( Talion...
Items per page:
1 - 10 of 24